Geoffrey A. Manne

Geoffrey A. Manne is the president and founder of the International Center for Law and Economics (ICLE), a nonprofit, nonpartisan research center based in Portland, Oregon. He is also a distinguished fellow at Northwestern University’s Center on Law, Business, and Economics. Manne holds AB & JD degrees from the University of Chicago. He is an expert in the economic analysis of law, focusing particularly on antitrust, telecom, IP, and the regulation of technology. From 2003 to 2006 he taught law & economics, international economic regulation, corporations, and other courses at Lewis & Clark Law School. Prior to teaching, Manne practiced antitrust law and appellate litigation at Latham & Watkins, clerked for Hon. Morris S. Arnold on the 8th Circuit Court of Appeals, and worked as a research assistant for Judge Richard Posner. He was also once (very briefly) employed by the FTC. In 2006 he decamped from Lewis & Clark to work in Microsoft’s legal department, heading up a program on law & economics academic engagement. He subsequently founded ICLE in 2009. In 2017 he was appointed by FCC Chairman Ajit Pai to a two-year term on the FCC’s Broadband Deployment Advisory Committee, and before that he served for two years on the FCC’s Consumer Advisory Committee. His writings and publications are available at SSRN and ICLE.

 

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More